Discover 2,379 paid clinical trials in Plainfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Plainfield offers many clinical trial opportunities with focuses on various conditions, including ADHD, prurigo nodularis, autoimmune diseases like lupus, and cardiovascular conditions. The city's leading institutions are actively recruiting both healthy volunteers interested in paid research options, as well as those with specific health conditions for studies that could lead to groundbreaking discoveries and improved treatments.
Filter
2
Filter results
Results: 2,379
Active & Responsive
A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
for
FGFR2 Gene Fusion/Rearrangement, Other Solid Tumors, Adult
Location: Chicago IL, New York NY, Boston MA, Houston TX,
Sponsor: Elevar Therapeutics
Sex: All
Age: 18+
Code: NCT07359820
Phase 2, Recruiting
Active & Responsive
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
for
Bladder Cancer
Location: Chicago IL, Cleveland OH, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07232602
Phase 1, Phase 2, Recruiting
Active & Responsive
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
for
Short Bowel Syndrome
Location: Chicago IL, St Louis MO, Nashville TN, Omaha NE,
Sponsor: Zealand Pharma
Sex: All
Age: 18 - 70+
Code: NCT07197944
Phase 3, Recruiting
Active & Responsive
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
for
Type I Diabetes
Location: Chicago IL, Birmingham AL, Aurora CO, Renton WA,
Sponsor: Op-T LLC
Sex: All
Age: 18 - 50
Code: NCT06964087
Phase 2, Recruiting
Active & Responsive
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Chicago IL, St Louis MO, Detroit MI, Nashville TN,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 12+
Code: NCT05533697
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
for
Non-small Cell Lung Cancer, NSCLC
Location: Chicago IL, Ypsilanti MI, Minneapolis MN, Kitchener,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06422143
Phase 3, Recruiting
Active & Responsive
Food and Metabolism Study
for
Prediabetes, Insulin Resistance, Triglycerides,
Location: Chicago IL
Sponsor: Clinical Nutrition Research Center, Illinois Institute of Technology
Sex: All
Age: 40 - 70
Code: NCT07624500
Recruiting
Active & Responsive
Multi-Site Trial of Tirzepatide for Smoking Cessation
for
Smoking Cessation, Smoking Behaviors
Location: Chicago IL, New Haven CT, Aurora CO, Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 21 - 65
Code: NCT07602699
Phase 2, Recruiting
Active & Responsive
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
for
Ovarian Cancer, Fallopian Tube Cancer
Location: Chicago IL, St Louis MO, Rochester MN, Durham NC,
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT05287451
Recruiting
Active & Responsive
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
for
Intracranial Aneurysm
Location: Chicago IL, Park Ridge IL, Indianapolis IN,
Sponsor: Medtronic Neurovascular Clinical Affairs
Sex: All
Age: 18 - 70+
Code: NCT02998229
Recruiting
Active & Responsive
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
for
Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness,
Location: Chicago IL, Madison WI, Pittsburgh PA, Toronto,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 65
Code: NCT04786262
Phase 3, Recruiting
Active & Responsive
Cortical Recording and Stimulating Array Brain-Machine Interface